Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer

International Journal of Medical Sciences

Volumn 10, Issue 3, 2013, Pages 230-234

  Zhang, Hao ^a   Song, Yong Chun ^a   Dang, Cheng Xue ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biomarker; Colorectal cancer; Hypermethylation; Screening; SPG20; Stool DNA

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; FEASIBILITY STUDY; FECES ANALYSIS; FEMALE; GENETIC MARKER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; ONCOGENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SAMPLE; SENSITIVITY AND SPECIFICITY; SPASTIC PARAPLEGIA 20 GENE; TISSUE SAMPLE;

BIOMARKER.; COLORECTAL CANCER; HYPERMETHYLATION; SCREENING; SPG20; STOOL DNA;

AGED; COLORECTAL NEOPLASMS; DNA; DNA METHYLATION; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARAPLEGIA; PROMOTER REGIONS, GENETIC; PROTEINS;

EID: 84873326080     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5278     Document Type: Article

References (26)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA: A Cancer Journal for Clinicians. 2011.
2. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. The Lancet. 1996; 348: 1472-7.
3. de Wijkerslooth T, Bossuyt P, Dekker E. strategies in screening for colon carcinoma. Neth J Med. 2011; 69: 112-9.
4. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, et al. Colorectal cancer screening. Journal of the National Comprehensive Cancer Network. 2010; 8: 8-61.
5. Kisiel JB, Ahlquist DA. Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests. Journal of clinical gastroenterology. 2011; 45: 301.
6. van Dam L, Kuipers EJ, van Leerdam ME. Performance improvements of stool-based screening tests. Best Practice & Research Clinical Gastroenterology. 2010; 24: 479-92.
7. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiologic reviews. 2011; 33: 88-100.
8. Hellebrekers DMEI, Lentjes MHFM, Van Den Bosch SM, Melotte V, Wouters KAD, Daenen KLJ, et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clinical Cancer Research. 2009; 15: 3990-7.
9. Mayor R, Casadomé L, Azuara D, Moreno V, Clark S, Capella G, et al. Long-range epigenetic silencing at 2q14. 2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. British journal of cancer. 2009; 100: 1534-9.
10. Melotte V, Lentjes MHFM, van den Bosch SM, Hellebrekers DMEI, de Hoon JPJ, Wouters KAD, et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Journal of the National Cancer Institute. 2009; 101: 916-27.
11. Bakowska JC, Jupille H, Fatheddin P, Puertollano R, Blackstone C. Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking. Molecular biology of the cell. 2007; 18: 1683-92.
12. Lind G, Raiborg C, Danielsen S, Rognum T, Thiis-Evensen E, Hoff G, et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene. 2011; 30: 3967-78.
13. Klaassen CHW, Jeunink MAF, Prinsen CFM, Ruers TJM, Tan AC, Strobbe LJA, et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clinical chemistry. 2003; 49: 1185-7.
14. Ahlquist DA. Molecular detection of colorectal neoplasia. Gastroenterology. 2010; 138: 2127-39.
15. Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer research. 2009; 69: 4691.
16. Kim MS, Louwagie J, Carvalho B, sive Droste JST, Park HL, Chae YK, et al. Promoter DNA methylation of oncostatin m receptor-β as a novel diagnostic and therapeutic marker in colon cancer. PLoS One. 2009; 4: e6555.
17. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Annals of internal medicine. 2008; 149: 441-50.
18. Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Diseases of the Colon & Rectum. 2009; 52: 1452.
19. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. The American journal of gastroenterology. 2008; 103: 2862-70.
20. Sagona AP, Stenmark H. Cytokinesis and cancer. FEBS letters. 2010; 584: 2652-61.
21. Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, et al. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepato-gastroenterology. 2010; 57: 720-7.
22. Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology-Journal of the RCPA. 2012; 44: 80.
23. Zou H, Allawi H, Cao X, Domanico M, Harrington J, Taylor WR, et al. Quantification of methylated markers with a multiplex methylation-specific technology. Clinical chemistry. 2012; 58: 375-83.
24. Deng L, Qi Z, Zou B, Wu H, Huang H, Kajiyama T, et al. Digital Detection of Multiple Minority Mutants in Stool DNA for Noninvasive Colorectal Cancer Diagnosis. Analytical chemistry. 2012; 84: 5645-52.
25. Ostwald C, Linnebacher M, Weirich V, Prall F. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. International journal of oncology. 2009; 35: 321.
26. Bosch LJW, Mongera S, sive Droste JST, Oort FA, van Turenhout ST, Penning MT, et al. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. Cellular Oncology. 2012;: 1-7.